目的：再评价运动想象疗法（motor imagery therapy，MIT）治疗卒中后运动功能障碍疗效的系统评价 （systematic review，SR）或Meta分析。方法：计算机检索国内外数据库中关于MIT治疗卒中后运动功能障 碍的 SR/Meta 分析，检索时限为建库至 2023 年 9 月。通过 AMSTAR 2 评价工具、PRISMA 2020 规范和 GRADE系统对纳入研究进行文献质量和证据质量评价。结果：最终纳入11篇文献。AMSTAR 2评价显示 有2篇中等质量（18.18%）、2篇低质量（18.18%）以及7篇极低质量文献（63.64%）。PRISMA 2020规范显示3 篇文献（27.27%）报告相对完整，8篇文献（72.73%）报告存在一定缺陷。GRADE证据评级显示共涉及49个 结局指标，其中2个中等质量（4.08%）、24个低质量（48.98%）和23个极低质量证据（63.64%）。结论：MIT有 助于卒中后肢体运动功能、平衡功能和日常生活能力的恢复。

To conduct a systematic re-evaluation of systematic reviews (SR) or Meta-analyses on the efficacy of motor imagery therapy (MIT) in treating post-stroke motor dysfunction. Methods: A computerized search was conducted in domestic and international databases for SR/Meta-analyses on MIT for post-stroke motor dysfunction, with the search period spanning from the establishment of the databases to September 2023. The AMSTAR 2 tool, PRISMA 2020 guidelines, and GRADE system were employed to evaluate the quality of the included studies in terms of literature quality and evidence quality. Results: Ultimately, 11 studies were included. According to the AMSTAR 2 assessment, there were 2 studies of moderate quality (18.18%), 2 studies of low quality (18.18%), and 7 studies of very low quality (63.64%). The PRISMA 2020 guidelines indicated that 3 studies (27.27% ) had relatively complete reporting, while 8 studies (72.73% ) had certain reporting deficiencies. The GRADE evidence grading revealed a total of 49 outcome indicators, among which 2 were of moderate quality (4.08% ), 24 were of low quality (48.98% ), and 23 were of very low quality evidence (63.64% ). Conclusion: MIT contributes to the recovery of limb motor function, balance function, and activities of daily living in post-stroke patients.